ALS Investment Fund
We are a Venture Capital fund that invests in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus on ALS.
By subscribing, I agree to Substack’s Terms of Use and acknowledge its Information Collection Notice and Privacy Policy